Protection conferred by virus-like particle vaccines against respiratory syncytial virus infection in mice by intranasal vaccination

Influenza virus vaccine expressing fusion and attachment protein epitopes of respiratory syncytial virus induces protective antibodies in BALB/c mice

(2014) Chengrong Bian et al.   ANTIVIRAL RESEARCH

Mucosal Immunization: A Review of Strategies and Challenges

(2014) Hinal Patel et al.   CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS

Proof of principle for epitope-focused vaccine design

(2014) Bruno E. Correia et al.   NATURE

Enhanced Influenza VLP vaccines comprising matrix-2 ectodomain and nucleoprotein epitopes protects mice from lethal challenge

(2013) Xiao Gao et al.   ANTIVIRAL RESEARCH

The Respiratory Syncytial Virus Fusion Protein and Neutrophils Mediate the Airway Mucin Response to Pathogenic Respiratory Syncytial Virus Infection

(2013) K. L. Stokes et al.   JOURNAL OF VIROLOGY

Reducing mortality from childhood pneumonia and diarrhoea: The leading priority is also the greatest opportunity

(2013) Igor Rudan et al.   Journal of Global Health

Role of secretory IgA in infection and maintenance of homeostasis

(2012) Blaise Corthésy   AUTOIMMUNITY REVIEWS

Mucosal IgA responses in influenza virus infections; thoughts for vaccine design

(2012) Elly van Riet et al.   VACCINE

Insect cell technology is a versatile and robust vaccine manufacturing platform

(2011) Jimmy A Mena et al.   Expert Review of Vaccines

Respiratory syncytial virus vaccine development

(2011) Julia L Hurwitz   Expert Review of Vaccines

Viruslike Particle Vaccine Induces Protection Against Respiratory Syncytial Virus Infection in Mice

(2011) Fu-Shi Quan et al.   JOURNAL OF INFECTIOUS DISEASES

Virus-like particles in vaccine development

(2010) António Roldão et al.   Expert Review of Vaccines

New insights for development of a safe and protective RSV vaccine

(2010) Jorge C. G. Blanco et al.   Human vaccines & immunotherapeutics

Molecular and structural characterization of the L1 virus-like particles that are used as vaccine antigens inCervarix™, the AS04-adjuvanted HPV-16 and -18 cervical cancer vaccine

(2010) Michel Deschuyteneer et al.   Human vaccines & immunotherapeutics

Assembly and Immunological Properties of Newcastle Disease Virus-Like Particles Containing the Respiratory Syncytial Virus F and G Proteins

(2010) L. W. McGinnes et al.   JOURNAL OF VIROLOGY

Respiratory syncytial virus prevention and therapy: Past, present, and future

(2010) Melvin Wright et al.   PEDIATRIC PULMONOLOGY

Newcastle Disease Virus-Like Particles Containing Respiratory Syncytial Virus G Protein Induced Protection in BALB/c Mice, with No Evidence of Immunopathology

(2009) M. R. Murawski et al.   JOURNAL OF VIROLOGY